Research ArticleINFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA
Pharmacology of PF-4191834, a Novel, Selective Non-Redox 5-Lipoxygenase Inhibitor Effective in Inflammation and Pain
Jaime L. Masferrer, Ben S. Zweifel, Medora Hardy, Gary D. Anderson, Dawn Dufield, Luz Cortes-Burgos, Robert A. Pufahl and Matthew Graneto
Journal of Pharmacology and Experimental Therapeutics July 2010, 334 (1) 294-301; DOI: https://doi.org/10.1124/jpet.110.166967
Jaime L. Masferrer
Ben S. Zweifel
Medora Hardy
Gary D. Anderson
Dawn Dufield
Luz Cortes-Burgos
Robert A. Pufahl
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleINFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA
Pharmacology of PF-4191834, a Novel, Selective Non-Redox 5-Lipoxygenase Inhibitor Effective in Inflammation and Pain
Jaime L. Masferrer, Ben S. Zweifel, Medora Hardy, Gary D. Anderson, Dawn Dufield, Luz Cortes-Burgos, Robert A. Pufahl and Matthew Graneto
Journal of Pharmacology and Experimental Therapeutics July 1, 2010, 334 (1) 294-301; DOI: https://doi.org/10.1124/jpet.110.166967
Research ArticleINFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA
Pharmacology of PF-4191834, a Novel, Selective Non-Redox 5-Lipoxygenase Inhibitor Effective in Inflammation and Pain
Jaime L. Masferrer, Ben S. Zweifel, Medora Hardy, Gary D. Anderson, Dawn Dufield, Luz Cortes-Burgos, Robert A. Pufahl and Matthew Graneto
Journal of Pharmacology and Experimental Therapeutics July 1, 2010, 334 (1) 294-301; DOI: https://doi.org/10.1124/jpet.110.166967
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement